NEW YORK, June 19 - Toshiba and the Institute of Human Virology will study ways in which a pharmacogenomics technology developed by the Japanese electronics giant can be used to improve the efficacy of HIV drugs, the partners said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.
The Wall Street Journal looks into the cost of new gene therapies.
An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.
In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.